Skip to content
Adam Torkildson – Lifestyle
Author:
Kymera Therapeutics, Inc.
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
March 28, 2026
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
March 10, 2026
←
Previous Page
1
2